Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-10-22 9:37 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | ELI LILLY & Co 10% Owner | 0 | $0 | 1,104,558 (Direct) | View |
Ownership | 2026-10-22 9:25 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Venrock Healthcare Capital Partners XP L.P. VHCP Management XP LLC Koh Bong Y Shah Nimish P 10% Owner | 0 | $0 | 4,779,793 (Indirect) | View |
Ownership | 2026-10-22 7:23 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | Bertozzi Carolyn R 10% Owner | 0 | $0 | 904,821 (Direct) | View |
Ownership | 2026-10-22 7:21 pm | N/A 2036-08-10 | Lycia Therapeutics Inc. | LYCA | Henderson Jane Director | 0 | $0 | 57,666 (Direct) | View |
Ownership | 2026-10-22 7:20 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | Versant Ventures VII GP L.P. Versant Venture Capital VII L.P. Versant Ventures VII GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 0 | $0 | 31,675,007 (Indirect) | View |
Ownership | 2026-10-22 7:19 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | Fischer Laurent Director | 0 | $0 | 59,883 (Direct) | View |
Ownership | 2026-10-22 7:18 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | RIEFLIN WILLIAM JL Director | 0 | $0 | 148,998 (Indirect) | View |
Ownership | 2026-10-22 7:16 pm | N/A 2033-08-13 | Lycia Therapeutics Inc. | LYCA | Touami Sofia Chief Business Officer | 0 | $0 | 332,245 (Direct) | View |
Ownership | 2026-10-22 7:15 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | Staben Steven Chief Scientific Officer 10% Owner | 0 | $0 | 510,123 (Direct) | View |
Ownership | 2026-10-22 7:13 pm | N/A 2035-02-12 | Lycia Therapeutics Inc. | LYCA | Lee Chin Hyok Chief Medical Officer 10% Owner | 0 | $0 | 439,593 (Direct) | View |
Ownership | 2026-10-22 7:11 pm | N/A 2036-08-10 | Lycia Therapeutics Inc. | LYCA | Bachrodt Amy Chief Financial Officer 10% Owner | 0 | $0 | 399,746 (Direct) | View |
Ownership | 2026-10-22 7:10 pm | N/A N/A | Lycia Therapeutics Inc. | LYCA | Trombley Aetna Wun President and CEO 10% Owner | 0 | $0 | 2,050,921 (Indirect) | View |